Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting - Yahoo Finance -BoardProspects

Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting

Yahoo Finance Apr 1 2022 BoardMoves

Takeda today announced that its Board of Directors will propose two new candidates for independent external directors at the 146 th Ordinary Meeting of Shareholders on June 29, 2022. The new candidates, Kimberly A. Reed and John Maraganore, who – if approved – will join the Board effective June 29, will succeed Toshiyuki Shiga and Shiro Kuniya who have announced their intention to retire...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- A New Diversity Monitor for the S.E.C. - NYTimes.com also categorized in BoardMoves
- Google Names VMware Cofounder Diane Greene To Its Board also categorized in BoardMoves
- Time Inc. Appoints Griffin CEO also categorized in BoardMoves
- Microsoft Adds New Board Member also categorized in BoardMoves
- NACD BoardVision - NACD BoardVision – “The role of the board as company spokesperson” - Resources - NACD also mentions National Association of Corporate Directors
- Shareholders Back Calls for Premier Foods Chief to Go also published in Yahoo Finance
- Thompson Joins Microsoft Board also categorized in BoardMoves
- Mellanox, Starboard Select Directors to Join Board also published in Yahoo Finance
- Yahoo! Names Thompson CEO also categorized in BoardMoves
- Qualcomm co-founder to retire from board in 2012 also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Quotes
1. I would like to thank Masahiro for his work as chair of the Board Meetings. Takeda's transformation and current success was greatly impacted by his leadership. I am confident that Masami, if approved as member of the Board, will chair our Board meeting very effectively.
2. Takeda is striving to develop its governance even further. We want to continue advancing the diversity of the Board, both in gender and nationalities, while ensuring good representation of our Japanese and international stakeholders without expanding the Board further.
3. I admire Takeda's transformation journey into a top-tier global pharmaceutical company and, if approved, I look forward to working alongside the rest of the Board to support the company's mission to deliver breakthrough medicines through its leading science and commercial capabilities.
Topics Mentioned